Search research articles
Contact Us
Filters
Showing results (1-10 of 231) with videos related to
Page
of 24
Sort By:
Nuclear Medicine and Biology
|
April 29, 2022
Tracer development for PET imaging of proteinopathies
Annukka Kallinen, Michael Kassiou
Mini Reviews in Medicinal Chemistry
|
November 17, 2004
Development of radioligands for in vivo imaging of GABA(A)-benzodiazepine receptors
Andrew Katsifis, Michael Kassiou
Expert Opinion on Therapeutic Patents
|
March 9, 2010
P2X purinergic receptor ligands: recently patented compounds
Hendra Gunosewoyo, Michael Kassiou
Methods in Molecular Biology (Clifton, N.J.)
|
September 22, 2021
Measuring Affinity of Ligands to the Oxytocin Receptor Using Radioligand Binding
Eryn L Werry, Michael Kassiou
Current Pharmaceutical Design
|
February 1, 2012
The therapeutic potential of sigma (σ) receptors for the treatment of central nervous system diseases: evaluation of the evidence
Samuel D Banister, Michael Kassiou
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 19, 2011
The translocator protein
Alana M Scarf, Michael Kassiou
Expert Opinion on Therapeutic Patents
|
September 15, 2017
A patent review of oxytocin receptor antagonists 2013-2017
Timothy A Katte, Michael Kassiou
European Journal of Drug Metabolism and Pharmacokinetics
|
May 21, 2004
The role of positron emission tomography in the discovery and development of new drugs; as studied in laboratory animals
Peter Roselt, Steven Meikle, Michael Kassiou
Current Medicinal Chemistry
|
July 18, 2006
Development of ligands for the peripheral benzodiazepine receptor
Michelle L James, Silvia Selleri, Michael Kassiou
International Journal of Molecular Sciences
|
November 13, 2021
Senolytics: A Novel Strategy for Neuroprotection in ALS?
Alexandra Maximova, Eryn L Werry, Michael Kassiou
Page
of 24
Search research articles
Search
Showing results (1-10 of 231) with videos related to
Sort By:
Page
of 24
Nuclear Medicine and Biology
|
April 29, 2022
Tracer development for PET imaging of proteinopathies
Annukka Kallinen, Michael Kassiou
Mini Reviews in Medicinal Chemistry
|
November 17, 2004
Development of radioligands for in vivo imaging of GABA(A)-benzodiazepine receptors
Andrew Katsifis, Michael Kassiou
Expert Opinion on Therapeutic Patents
|
March 9, 2010
P2X purinergic receptor ligands: recently patented compounds
Hendra Gunosewoyo, Michael Kassiou
Methods in Molecular Biology (Clifton, N.J.)
|
September 22, 2021
Measuring Affinity of Ligands to the Oxytocin Receptor Using Radioligand Binding
Eryn L Werry, Michael Kassiou
Current Pharmaceutical Design
|
February 1, 2012
The therapeutic potential of sigma (σ) receptors for the treatment of central nervous system diseases: evaluation of the evidence
Samuel D Banister, Michael Kassiou
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 19, 2011
The translocator protein
Alana M Scarf, Michael Kassiou
Expert Opinion on Therapeutic Patents
|
September 15, 2017
A patent review of oxytocin receptor antagonists 2013-2017
Timothy A Katte, Michael Kassiou
European Journal of Drug Metabolism and Pharmacokinetics
|
May 21, 2004
The role of positron emission tomography in the discovery and development of new drugs; as studied in laboratory animals
Peter Roselt, Steven Meikle, Michael Kassiou
Current Medicinal Chemistry
|
July 18, 2006
Development of ligands for the peripheral benzodiazepine receptor
Michelle L James, Silvia Selleri, Michael Kassiou
International Journal of Molecular Sciences
|
November 13, 2021
Senolytics: A Novel Strategy for Neuroprotection in ALS?
Alexandra Maximova, Eryn L Werry, Michael Kassiou
Page
of 24